6/3
04:00 pm
snse
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) had its "buy" rating re-affirmed by analysts at Citigroup Inc.. They now have a $4.00 price target on the stock.
Medium
Report
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) had its "buy" rating re-affirmed by analysts at Citigroup Inc.. They now have a $4.00 price target on the stock.
6/3
03:11 pm
snse
Rating for SNSE
Low
Report
Rating for SNSE
6/3
03:11 pm
snse
Rating for SNSE
Low
Report
Rating for SNSE
5/24
01:04 pm
snse
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Medium
Report
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
5/24
12:18 pm
snse
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $5.00 price target on the stock.
Medium
Report
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $5.00 price target on the stock.
5/24
12:18 pm
snse
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $5.00 price target on the stock.
Medium
Report
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $5.00 price target on the stock.
5/24
11:44 am
snse
Rating for SNSE
High
Report
Rating for SNSE
5/14
08:07 am
snse
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) is now covered by analysts at Stephens. They set an "overweight" rating and a $5.00 price target on the stock.
Medium
Report
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) is now covered by analysts at Stephens. They set an "overweight" rating and a $5.00 price target on the stock.
5/14
08:07 am
snse
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) is now covered by analysts at Stephens. They set an "overweight" rating and a $5.00 price target on the stock.
Medium
Report
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) is now covered by analysts at Stephens. They set an "overweight" rating and a $5.00 price target on the stock.
5/14
05:47 am
snse
Rating for SNSE
High
Report
Rating for SNSE